Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-cell mediated desensitization refers to the process by which the immune system, particularly T cells, is modulated to reduce or eliminate hypersensitivity reactions to specific antigens (such as allergens or drugs). This process is central in allergen immunotherapy and drug desensitization protocols, aiming to induce tolerance and prevent adverse immune responses. It involves induction/expansion of regulatory T cell populations, suppression/anergy/deletion of effector T cell populations, and increased production of anti-inflammatory cytokines such as IL-10 and IL-35.
Induction/expansion of regulatory T cells, suppression/anergy/deletion of effector T cells, increased production of anti-inflammatory cytokines (IL-10, IL-35)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune system (T-cell mediated desensitization).